Keith A. Goldan, Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), bought 1,250 shares at $20.03 ($25K) on 2024-06-14, disclosed to the SEC on 2024-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SNDX | SELL | 2026-02-06 | $43K | — | Filing → |
| SNDX | SELL | 2025-07-18 | $12K | — | Filing → |
| SNDX | SELL | 2025-02-12 | $117K | — | Filing → |